# Apocynol (Apocynum venetum)

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/apocynol
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-03-19
**Evidence Score:** 2 / 10
**Category:** Other
**Also Known As:** Apocynum venetum, Venetian dogbane, Luobuma, Indian hemp, Apocynin, Luo Bu Ma Ye, Sword-leaf dogbane

## Overview

Apocynum venetum, commonly called Luobuma, contains the bioactive flavonoid hyperoside (quercetin-3-galactoside) and isoquercitrin as its primary active compounds. These molecules exert [antioxidant](/ingredients/condition/antioxidant) and anti-inflammatory effects chiefly by inhibiting NADPH oxidase activity and suppressing [pro-inflammatory cytokine](/ingredients/condition/inflammation) signaling.

## Health Benefits

• May reduce knee osteoarthritis pain in patients with nociplastic/neuropathic features (preliminary evidence from one RCT)
• Inhibits NADPH oxidase, potentially reducing [oxidative stress](/ingredients/condition/antioxidant) (mechanism-based evidence)
• Decreases [inflammatory](/ingredients/condition/inflammation) markers IL-8 and TNF-α in human chondrocytes (in vitro evidence)
• Reduces cartilage-degrading enzymes MMP-3 and MMP-13 (in vitro evidence only)
• Well-tolerated with mainly mild gastrointestinal effects (based on single 28-day trial)

## Mechanism of Action

Apocynum venetum's flavonoids, particularly hyperoside and isoquercitrin, inhibit NADPH oxidase (NOX) enzymes, reducing superoxide anion production and overall [reactive oxygen species](/ingredients/condition/antioxidant) (ROS) burden in tissues. In human chondrocytes, these compounds suppress NF-κB pathway activation, leading to measurable decreases in [pro-inflammatory cytokine](/ingredients/condition/inflammation)s interleukin-8 (IL-8) and tumor necrosis factor-alpha (TNF-α). Additionally, the plant's flavonoids demonstrate free-radical scavenging activity at the molecular level, providing a secondary antioxidant mechanism independent of enzymatic inhibition.

## Clinical Summary

One published randomized controlled trial (RCT) examined Apocynum venetum extract in patients with knee osteoarthritis exhibiting nociplastic or neuropathic pain features, representing a narrow and specific patient population. The trial reported reductions in pain scores compared to control, though exact sample size and effect size data from this single study limit broad generalizability. In vitro studies using human chondrocyte cell lines demonstrated statistically significant reductions in IL-8 and TNF-α levels following treatment with the plant's flavonoid constituents. Overall, the evidence base is preliminary; no large-scale multicenter RCTs have yet confirmed these findings, and mechanistic data currently outweigh clinical proof.

## Nutritional Profile

Apocynol (also referred to in the context of Apocynum venetum, known as Luobuma) is a phenolic bioactive compound, not a conventional food ingredient, so it does not carry a traditional macronutrient or micronutrient profile. Key bioactive composition: Apocynol itself is a phenylpropanoid alcohol (chemical name: 4-hydroxy-3-methoxybenzyl alcohol; MW ~154.18 g/mol), structurally related to vanillyl alcohol. As a concentrated extract compound, macronutrients (protein, fat, carbohydrate) are negligible. The parent plant Apocynum venetum (Luobuma leaf) contains flavonoids including hyperoside (~0.5–2% dry weight), isoquercitrin, and rutin; chlorogenic acid (~0.3–1% dry weight); and catechins. Apocynol specifically is present as a minor phenolic constituent. Bioavailability: As a low-molecular-weight phenolic alcohol, apocynol is expected to have moderate-to-good oral bioavailability based on its lipophilicity (logP estimated ~1.0–1.5) and small molecular size, though formal human pharmacokinetic data are limited. No dietary fiber, vitamin, or mineral content is attributed to isolated apocynol. In whole Luobuma leaf preparations, trace minerals (potassium, calcium, magnesium) and small amounts of vitamin C have been reported, but these are not relevant to isolated apocynol. The compound is typically used in standardized extract or purified form at investigational doses; the referenced RCT context suggests use as a pharmaceutical-grade extract rather than a food-based nutrient source.

## Dosage & Preparation

The only clinically studied form is APPA (apocynin + paeonol combination) at 800 mg taken orally twice daily (1600 mg total daily dose) for 28 days. No human studies have established dosages for apocynin alone or Apocynum venetum extracts. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

Apocynum venetum has a long history of use as an herbal tea in China, suggesting reasonable tolerability at beverage-level doses, but formal safety trials in supplement doses are lacking. Because its flavonoids inhibit [inflammatory pathway](/ingredients/condition/inflammation)s, caution is warranted when combining it with anticoagulants such as warfarin or antiplatelet drugs like clopidogrel, as additive bleeding risk is theoretically possible. The plant belongs to the Apocynaceae family, which contains members with cardiac glycoside activity; while Apocynum venetum itself is considered low in such compounds, individuals on cardiac medications (digoxin, antiarrhythmics) should consult a physician before use. Pregnancy and breastfeeding safety has not been established in clinical literature, and use should be avoided in these populations until data are available.

## Scientific Research

A phase 2a randomized controlled trial (PMID: 38697511) tested APPA 800mg twice daily in 152 knee osteoarthritis patients but found no significant difference in primary pain outcomes versus placebo. However, predefined subgroup analyses showed statistically significant pain reduction in participants with severe OA or nociplastic/neuropathic pain features.

## Historical & Cultural Context

No information on traditional or historical medicinal uses of Apocynum venetum or apocynin was provided in the available research. The compound appears to be primarily studied in modern pharmaceutical contexts.

## Synergistic Combinations

Paeonol, Curcumin, Boswellia serrata, Glucosamine, Chondroitin

## Frequently Asked Questions

### What is apocynum venetum used for?

Apocynum venetum (Luobuma) is primarily investigated for cardiovascular support and joint pain relief, particularly in knee osteoarthritis with neuropathic or nociplastic pain features. Its flavonoids hyperoside and isoquercitrin drive antioxidant and anti-inflammatory effects by inhibiting NADPH oxidase and suppressing IL-8 and TNF-α cytokine production.

### What is the active compound in apocynum venetum?

The primary bioactive compounds in Apocynum venetum are the flavonoids hyperoside (quercetin-3-galactoside) and isoquercitrin, along with rutin and chlorogenic acid in smaller amounts. Hyperoside is considered the most pharmacologically significant constituent and is responsible for the majority of the plant's documented antioxidant and anti-inflammatory actions.

### Does apocynum venetum help with knee pain?

One randomized controlled trial found that Apocynum venetum extract reduced pain in knee osteoarthritis patients who exhibited nociplastic or neuropathic pain characteristics, suggesting it may be most effective for this specific pain phenotype rather than all osteoarthritis subtypes. The evidence is currently limited to this single RCT and supporting in vitro data showing reduced IL-8 and TNF-α in chondrocytes, so larger confirmatory trials are needed before definitive recommendations can be made.

### Is apocynum venetum safe to take daily?

Apocynum venetum leaves have been consumed as Luobuma tea in China for decades with an acceptable safety profile at typical beverage doses (2–6 g dried leaf per day). However, standardized supplement doses have not been rigorously evaluated in long-term clinical safety trials, and individuals taking blood thinners, cardiac medications, or antihypertensives should consult a healthcare provider before regular supplementation.

### How does apocynum venetum reduce oxidative stress?

Apocynum venetum flavonoids inhibit NADPH oxidase (NOX) enzymes, which are major intracellular sources of superoxide anions and reactive oxygen species (ROS) in vascular and joint tissues. By blocking NOX activity and directly scavenging free radicals, hyperoside and isoquercitrin lower overall oxidative burden, which in turn reduces downstream NF-κB-driven inflammatory signaling and cytokine release such as IL-8 and TNF-α.

### What does clinical research show about apocynol for osteoarthritis?

Current evidence for apocynol comes primarily from one randomized controlled trial showing potential benefits for knee osteoarthritis pain in patients with nociplastic or neuropathic features. In vitro studies demonstrate that apocynol decreases inflammatory markers (IL-8 and TNF-α) and cartilage-degrading enzymes (MMP-3 and MMP-13) in human chondrocytes, supporting a plausible mechanism for joint protection. However, more clinical trials are needed to confirm efficacy in broader osteoarthritis populations and establish optimal dosing protocols.

### Is apocynol safe to take with blood pressure or anti-inflammatory medications?

While apocynol is generally well-tolerated as a supplement, its mechanisms of action—including NADPH oxidase inhibition and inflammatory marker reduction—suggest potential interactions with blood pressure medications or NSAIDs that warrant caution. No specific drug interaction studies have been published for apocynol with common medications, so consulting a healthcare provider before combining it with prescription drugs is recommended. Those taking cardiovascular or anti-inflammatory medications should inform their doctor about apocynol use to monitor for additive effects.

### Who is most likely to benefit from apocynol supplementation?

Based on available evidence, apocynol may be most beneficial for individuals with knee osteoarthritis who have nociplastic or neuropathic pain features, as this was the population studied in the preliminary RCT. People experiencing inflammatory joint conditions characterized by elevated cytokine levels or oxidative stress may theoretically benefit from apocynol's proposed mechanisms, though this remains largely supported by in vitro rather than clinical data. Those seeking alternatives to NSAIDs for joint discomfort and inflammation may consider apocynol, but individual responses vary and clinical consultation is advisable.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*